Search for: "Celgene Corp." Results 61 - 80 of 81
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Aug 2010, 2:19 pm by Phil
The following is excerpted from an August 25, 2010 article by Thomas Gryta at The Wall Street Journal: Celgene Corp. is planning to fight the recent generic challenge to its blood cancer drug, Revlimid, and has been plotting its strategy for years. [read post]
14 Jul 2010, 6:47 pm by Kelly
Cetuximab has its day in Court: Yeda Research and Development Company Ltd v Comptroller General of Patents (SPC blog) Focalin (Dexmethylphenidate) – US: Patent infringement complaint following Paragraph IV certification: Celgene Corp. et al. v. [read post]
21 Jun 2010, 7:29 am by Theo Francis
Browsing through Friday afternoon’s filings over the Father’s Day weekend, we found an 8-K filed by biopharmaceutical maker Celgene Corp. [read post]
3 Jun 2010, 9:36 pm by Patent Docs
By James DeGiulio -- Celgene, Barr Resolve Patent Dispute over Generic Thalomid Celgene Corp. and Barr Laboratories Inc. have resolved their patent dispute over the multiple myeloma cancer drug Thalomid, with Celgene agreeing to drop its patent infringement claims and Barr dropping its invalidity and antitrust claims. [read post]
10 May 2010, 9:34 pm by Patent Docs
By James DeGiulio -- Celgene and Novartis Reach Settlement with Barr Laboratories in Ritalin ANDA Suit Celgene Corp. and Novartis AG have reached a settlement with Barr Laboratories Inc. over Barr's attempt to market a generic version of the ADHD drug Ritalin. [read post]
5 May 2010, 4:46 am
(Patent Docs) Intuniv (Guanfacine) – US: Shire files patent suit against Teva over its plans to market generic Intuniv (Patent Quality Review Blog) (Patent Docs) Istodax (Romidepsin) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. v. [read post]
1 Dec 2009, 9:39 am
" The New Jersey magistrate (Bongiovanni ) did not get into these issues: "New Jersey simply does not permit concurrent representation when the interests of two current clients are adverse," quoting Celgene Corp., v. [read post]
2 Jan 2009, 2:39 pm
The Dow Jones (12/31, Dooren) reported, "The Food and Drug Administration said Wednesday Celgene Corp. [read post]
2 Jan 2009, 2:36 pm
The Dow Jones (12/31, Dooren) reported, "The Food and Drug Administration said Wednesday Celgene Corp. [read post]
1 Oct 2008, 3:58 pm
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, And Erythema Multiforme Are Associated With Revlimid Use (Posted by Tom Lamb at DrugInjuryWatch.com) The Summer 2008 edition of the US FDA's Drug Safety Newsletter included an article concerning Revlimid (lenalidomide), a thalidomide analogue marketed by Celgene Corp. [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46)   Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences: (Managing… [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
25 Jul 2008, 7:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
20 Jun 2008, 8:07 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Nov 2007, 11:00 pm
: (PLI), (PatentDocs), (Patent Baristas), (Patently'O), Vonage settles patent dispure with Verizon: (IP Law360), Celgene and Novartis file extended release Ritalin suit: (IP Law360), T-Mobile USA is the latest to settle charges that it infringed technology for computerized sales methods held by patent-holding company Orion IP LLC: (IP Law360),Bayer beats Dr Reddy's on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals), Martek obtains permanent injunction agains… [read post]
25 Sep 2007, 8:38 pm
By Jason Derry -- Array BioPharma Inc. and Celgene Corp. have announced an agreement to collaborate in discovery, development, and commercialization of therapeutics for cancer and inflammation. [read post]